122 related articles for article (PubMed ID: 2298418)
1. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma.
Rehn S; Glimelius B; Strang P; Sundström C; Tribukait B
Hematol Oncol; 1990; 8(1):1-12. PubMed ID: 2298418
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma.
Christensson B; Lindemalm C; Johansson B; Mellstedt H; Tribukait B; Biberfeld P
Leuk Res; 1989; 13(4):307-14. PubMed ID: 2716347
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of proliferation-associated parameters in B-cell non-Hodgkin lymphoma.
Rehn S; Glimelius B; Sundström C
Hematol Oncol; 1991; 9(6):287-98. PubMed ID: 1748395
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of serum lactic dehydrogenase levels and fraction of S-phase cells in non-Hodgkin lymphomas.
Lindh J; Lenner P; Osterman B; Roos G
Eur J Haematol; 1993 May; 50(5):258-63. PubMed ID: 8319787
[TBL] [Abstract][Full Text] [Related]
6. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
Cowan RA; Harris M; Jones M; Crowther D
Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
[TBL] [Abstract][Full Text] [Related]
7. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
Joensuu H; Klemi PJ; Söderström KO; Jalkanen S
Cancer; 1991 Oct; 68(7):1564-71. PubMed ID: 1893358
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
[TBL] [Abstract][Full Text] [Related]
9. Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The Southeastern Cancer Study Group experience.
Wain SL; Braylan RC; Borowitz MJ
Cancer; 1987 Nov; 60(10):2403-11. PubMed ID: 3499212
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphoma.
Roos G; Dige U; Lenner P; Lindh J; Johansson H
Hematol Oncol; 1985; 3(4):233-42. PubMed ID: 4085977
[TBL] [Abstract][Full Text] [Related]
11. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic, predictive and prognostic verification of DNA flow cytometric measurements performed at diagnosis for non-Hodgkin's lymphoma adult patients.
Lackowska B; Gruchała A; Jaszcz-Gruchała A; Rolski J; Zemełka T; Dańda D; Ryś J
Pol J Pathol; 2012 Mar; 63(1):18-24. PubMed ID: 22535602
[TBL] [Abstract][Full Text] [Related]
13. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.
Akerman M; Brandt L; Johnson A; Olsson H
Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492
[TBL] [Abstract][Full Text] [Related]
14. 'Aggressive' low grade lymphocytic lymphomas can be identified by flow cytometric S-phase determinations.
Lindh J; Jonsson H; Lenner P; Roos G
Hematol Oncol; 1992; 10(3-4):171-9. PubMed ID: 1398513
[TBL] [Abstract][Full Text] [Related]
15. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
Joensuu H; Klemi PJ; Jalkanen S
Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material.
Young GA; Hedley DW; Rugg CA; Iland HJ
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1497-504. PubMed ID: 3678313
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.
Christensson B; Tribukait B; Linder IL; Ullman B; Biberfeld P
Cancer; 1986 Sep; 58(6):1295-304. PubMed ID: 3742454
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin lymphoma. Multivariate analysis of prognostic factors including fraction of S-phase cells.
Lenner P; Roos G; Johansson H; Lindh J; Dige U
Acta Oncol; 1987; 26(3):179-83. PubMed ID: 3651263
[TBL] [Abstract][Full Text] [Related]
20. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]